journal article·2022-12Open access

Influence of Impurities from Manufacturing Process on the Toxicity Profile of Boron Nitride Nanotubes

Vamsi Kodali, Keun Su Kim, Jenny R. Roberts, Lauren Bowers, Michael G. Wolfarth, John Hubczak, Xing Xin, Tracy Eye, Sherri Friend, Aleksandr B. Stefaniak, Stephen S. Leonard, Michael Jakubinek, Aaron Erdely

Small· Volume 18· Issue 52

Abstract

Abstract The toxicity of boron nitride nanotubes (BNNTs) has been the subject of conflicting reports, likely due to differences in the residuals and impurities that can make up to 30–60% of the material produced based on the manufacturing processes and purification employed. Four BNNTs manufactured by induction thermal plasma process with a gradient of BNNT purity levels achieved through sequential gas purification, water and solvent washing, allowed assessing the influence of these residuals/impurities on the toxicity profile of BNNTs. Extensive characterization including infrared and X‐ray spectroscopy, thermogravimetric analysis, size, charge, surface area, and density captured the alteration in physicochemical properties as the material went through sequential purification. The material from each step is screened using acellular and in vitro assays for evaluating general toxicity, mechanisms of toxicity, and macrophage function. As the material increased in purity, there are more high‐aspect‐ratio particulates and a corresponding distinct increase in cytotoxicity, nuclear factor‐κB transcription, and inflammasome activation. There is no alteration in macrophage function after BNNT exposure with all purity grades. The cytotoxicity and mechanism of screening clustered with the purity grade of BNNTs, illustrating that greater purity of BNNT corresponds to greater toxicity.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Boron and Carbon Nanomaterials Research · Thermal properties of materials · Carbon Nanotubes in Composites

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Health Effects Laboratory Division National Institute for Occupational Safety and Health Morgantown WV 26505 USA

Department of Physiology and Pharmacology School of Medicine West Virginia University Morgantown WV 26506 USA

Division of Emerging Technologies National Research Council Canada 100 Sussex Drive Ottawa ON K1A 0R6 Canada

Respiratory Health Division National Institute for Occupational Safety and Health Morgantown WV 26505 USA

Department of Pharmaceutical Science School of Pharmacy West Virginia University Morgantown WV 26506 USA

Funding

National Institute for Occupational Safety and Health · National Research Council Canada

References (94)

Show source-provided references
1. 10.1016/B978-0-12-812667-7.00005-710.1016/B978-0-12-812667-7.00005-7 ↗
2. 10.1021/acsomega.1c0258610.1021/acsomega.1c02586 ↗
3. 10.1186/s40580-018-0149-y10.1186/s40580-018-0149-y ↗
4. 10.1021/cm000157q10.1021/cm000157q ↗
5. 10.1021/nl051859n10.1021/nl051859n ↗
6. 10.1088/0957-4484/23/21/21560110.1088/0957-4484/23/21/215601 ↗
7. 10.1021/acsomega.1c0436110.1021/acsomega.1c04361 ↗
8. Tiano A. · 2014
9. 10.1039/D0NA00136H10.1039/D0NA00136H ↗
10. 10.1039/C8NA00251G10.1039/C8NA00251G ↗
11. S.Hales J.Alexa B.Jensen Radio Frequency Plasma Synthesis of Boron Nitride Nanotubes (BNNTs) for Structural Applications: Part II. Center N. L. R. Ed. NASA: Hampton 2016.
12. 10.4236/jmp.2011.2810210.4236/jmp.2011.28102 ↗
13. 10.1021/acs.chemmater.0c0360910.1021/acs.chemmater.0c03609 ↗
14. 10.1186/1556-276X-7-41710.1186/1556-276X-7-417 ↗
15. 10.1039/C4RA01204F10.1039/C4RA01204F ↗
16. 10.1021/acs.chemmater.0c0014410.1021/acs.chemmater.0c00144 ↗
17. 10.1016/j.cplett.2006.05.05810.1016/j.cplett.2006.05.058 ↗
18. 10.1021/acs.chemmater.9b0171310.1021/acs.chemmater.9b01713 ↗
19. 10.1021/acs.chemmater.8b0378510.1021/acs.chemmater.8b03785 ↗
20. 10.1039/C8NA00315G10.1039/C8NA00315G ↗
21. 10.1021/acs.chemmater.1c0116510.1021/acs.chemmater.1c01165 ↗
22. 10.1021/acsnano.7b0870810.1021/acsnano.7b08708 ↗
23. 10.1021/nn501661p10.1021/nn501661p ↗
24. 10.1088/0957-4484/22/14/14560210.1088/0957-4484/22/14/145602 ↗
25. 10.1088/0957-4484/20/50/50560410.1088/0957-4484/20/50/505604 ↗
26. 10.1080/17435390.2017.139017710.1080/17435390.2017.1390177 ↗
27. 10.1016/j.impact.2020.10023510.1016/j.impact.2020.100235 ↗
28. 10.1039/C9NA00104B10.1039/C9NA00104B ↗
29. 10.1021/nn200139h10.1021/nn200139h ↗
30. 10.2217/nnm.14.2510.2217/nnm.14.25 ↗
31. 10.2147/IJN.S987910.2147/IJN.S9879 ↗
32. 10.1002/bit.2195210.1002/bit.21952 ↗
33. 10.1021/nn101985a10.1021/nn101985a ↗
34. 10.1016/j.bbrc.2010.03.03510.1016/j.bbrc.2010.03.035 ↗
35. 10.1139/cjc-2018-043010.1139/cjc-2018-0430 ↗
36. 10.1289/ehp.826610.1289/ehp.8266 ↗
37. 10.1186/1743-8977-5-1710.1186/1743-8977-5-17 ↗
38. 10.1080/10937404.2015.105161110.1080/10937404.2015.1051611 ↗
39. 10.1007/978-3-319-19096-9_1810.1007/978-3-319-19096-9_18 ↗
40. 10.1021/nn301008710.1021/nn3010087 ↗
41. 10.3390/ma1310223510.3390/ma13102235 ↗
42. 10.1155/2013/94291610.1155/2013/942916 ↗
43. 10.1038/am.2012.6010.1038/am.2012.60 ↗
44. 10.1021/tx800100s10.1021/tx800100s ↗
45. 10.1016/j.toxlet.2006.02.00110.1016/j.toxlet.2006.02.001 ↗
46. 10.1016/j.impact.2020.10023410.1016/j.impact.2020.100234 ↗
47. 10.1021/cm021763j10.1021/cm021763j ↗
48. 10.1016/j.mattod.2021.09.01710.1016/j.mattod.2021.09.017 ↗
49. 10.1016/j.matlet.2016.04.00810.1016/j.matlet.2016.04.008 ↗
50. 10.3390/ijms2104152910.3390/ijms21041529 ↗
51. 10.1007/s00357-014-9161-z10.1007/s00357-014-9161-z ↗
52. 10.1186/s12989-016-0123-y10.1186/s12989-016-0123-y ↗
53. 10.1186/s12989-016-0162-410.1186/s12989-016-0162-4 ↗
54. 10.1016/j.envint.2020.10551010.1016/j.envint.2020.105510 ↗
55. Lin H. · J Environ Sci Health C Environ Carcinog Ecotoxicol Rev · 2021 · 56 · 333
56. 10.1073/pnas.92.18.845810.1073/pnas.92.18.8458 ↗
57. 10.1093/toxsci/kfy06410.1093/toxsci/kfy064 ↗
58. 10.1056/NEJM19970410336150610.1056/NEJM199704103361506 ↗
59. 10.1038/sigtrans.2017.2310.1038/sigtrans.2017.23 ↗
60. 10.1016/j.redox.2021.10216110.1016/j.redox.2021.102161 ↗
61. Castranova V. · 2002 · 17710.1007/978-1-4615-1087-1_20 ↗
62. 10.2147/IJN.S11046510.2147/IJN.S110465 ↗
63. 10.1016/j.tox.2008.12.02310.1016/j.tox.2008.12.023 ↗
64. 10.1021/tx200351d10.1021/tx200351d ↗
65. 10.3389/fphar.2019.0114010.3389/fphar.2019.01140 ↗
66. 10.1038/ni.163110.1038/ni.1631 ↗
67. 10.1021/nn200595c10.1021/nn200595c ↗
68. 10.1186/1743-8977-10-3910.1186/1743-8977-10-39 ↗
69. 10.1002/smll.20120196210.1002/smll.201201962 ↗
70. 10.1186/s12859-018-2089-210.1186/s12859-018-2089-2 ↗
71. 10.3389/fimmu.2019.0070510.3389/fimmu.2019.00705 ↗
72. 10.1289/ehp.130656110.1289/ehp.1306561 ↗
73. 10.3390/ijms2112429410.3390/ijms21124294 ↗
74. 10.1006/enrs.1994.100410.1006/enrs.1994.1004 ↗
75. 10.1056/NEJM19931209329240110.1056/NEJM199312093292401 ↗
76. 10.1164/rccm.200901-0160OC10.1164/rccm.200901-0160OC ↗
77. 10.1016/j.impact.2019.10015510.1016/j.impact.2019.100155 ↗
78. 10.1016/j.impact.2016.07.00110.1016/j.impact.2016.07.001 ↗
79. 10.1021/nn402145t10.1021/nn402145t ↗
80. 10.1165/rcmb.2007-0255OC10.1165/rcmb.2007-0255OC ↗
81. 10.1371/journal.pone.020941310.1371/journal.pone.0209413 ↗
82. 10.1080/0895837005016463510.1080/08958370050164635 ↗
83. 10.1093/toxsci/70.1.11010.1093/toxsci/70.1.110 ↗
84. Shannahan J. H. · Recept. Clin. Invest. · 2015 · 2 · e811
85. 10.1016/j.taap.2014.04.01010.1016/j.taap.2014.04.010 ↗
86. ASTM · 2020
87. 10.1080/1743539080231834910.1080/17435390802318349 ↗
88. 10.1186/s12989-020-00392-w10.1186/s12989-020-00392-w ↗
89. 10.1186/s12989-016-0145-510.1186/s12989-016-0145-5 ↗
90. EPA Benchmark Dose Software (BMDS) United States Environmental Protection Agency https://www.epa.gov/bmds(accessed: February 2022).
91. 10.1023/B:MCBI.0000007273.23747.6710.1023/B:MCBI.0000007273.23747.67 ↗
92. 10.1080/1545962090334907310.1080/15459620903349073 ↗
93. 10.1093/acprof:oso/9780198717478.001.000110.1093/acprof:oso/9780198717478.001.0001 ↗
94. 10.1177/00131644630230010710.1177/001316446302300107 ↗